
|Articles|May 15, 2004
Imaging analysis quantifies benefit of drug on eyelid swelling
Boston-A study using a novel, objective method for quantifying eyelid swelling reinforces the benefit of olopatadine HCl 0.1% (Patanol, Alcon) for reducing eyelid swelling triggered by allergen exposure, said Mark B. Abelson, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Neurotrophic keratitis outcomes improve with early, stage-based care
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Improved grading scales for oncology drugs causing ocular adverse events
4
Alcon raises offer in amended deal to acquire STAAR Surgical
5












































.png)


